Blockade of feeding inhibition by neuromedin B using a selective receptor antagonist.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 7698191)

Published in Eur J Pharmacol on December 12, 1994

Authors

E E Ladenheim1, J E Taylor, D H Coy, T H Moran

Author Affiliations

1: Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205.

Articles by these authors

A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet (1995) 4.95

Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun (1989) 3.03

Chlamydia transmission: concurrency, reproduction number, and the epidemic trajectory. Am J Epidemiol (1999) 2.76

Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65

Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry (2007) 2.53

The new economics of labour migration and the role of remittances in the migration process. Int Migr (1999) 2.22

Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol (1992) 2.22

Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport (2001) 2.19

Prenatal onset spinal muscular atrophy. Eur J Paediatr Neurol (1999) 2.15

Satiety after preloads with different amounts of fat and carbohydrate: implications for obesity. Am J Clin Nutr (1994) 1.97

Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum Mol Genet (2000) 1.96

Relative deprivation and international migration. Demography (1989) 1.93

Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci (1995) 1.90

Characterization of a putative cellular receptor for HIV-1 transmembrane glycoprotein using synthetic peptides. AIDS (1990) 1.77

Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin. Gastroenterology (1976) 1.74

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71

Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68

Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist. Gut (2001) 1.66

Hypothalamic regulatory hormones. Annu Rev Biochem (1978) 1.60

Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res (1986) 1.60

Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. Diabetologia (2008) 1.51

A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats. Am J Physiol Regul Integr Comp Physiol (2001) 1.45

Solid phase synthesis of growth hormone-release inhibiting factor. Biochem Biophys Res Commun (1973) 1.44

Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut (2004) 1.42

Transepithelial chemotaxis of rat peritoneal exudate cells. Br J Exp Pathol (1983) 1.40

Central leptin modulates behavioral and neural responsivity to CCK. Am J Physiol (1999) 1.39

Undetected excessive ultrafiltration and serious haemolysis during maintenance haemodialysis. Nephrol Dial Transplant (1993) 1.38

Development of an assay for the simultaneous determination of sildenafil (Viagra) and its metabolite (UK-103,320) using automated sequential trace enrichment of dialysates and high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (1997) 1.35

Physiology: does gut hormone PYY3-36 decrease food intake in rodents? Nature (2004) 1.34

Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors. J Biol Chem (1997) 1.33

International migration and national development. Popul Index (1996) 1.33

Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology (1991) 1.30

Nonopiate effects of dynorphin and des-Tyr-dynorphin. Science (1982) 1.29

The role of calcium in ABA-induced gene expression and stomatal movements. Plant J (2001) 1.29

Calories and gastric emptying: a regulatory capacity with implications for feeding. Am J Physiol (1979) 1.28

Radioimmunoassay for GH-release inhibiting hormone. Proc Soc Exp Biol Med (1975) 1.27

LH-RH agonists and antagonists. Int J Gynaecol Obstet (1980) 1.24

Growth hormone release inhibiting hormone in acromegaly. Br Med J (1974) 1.24

Radioimmunoassay of somatostatin. Metabolism (1978) 1.22

Sexual network structure as an indicator of epidemic phase. Sex Transm Infect (2002) 1.22

Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion. J Clin Invest (1976) 1.22

Progress in the development of potent bombesin receptor antagonists. Trends Pharmacol Sci (1991) 1.18

Coping with multiple enemies: an integration of molecular and ecological perspectives. Trends Plant Sci (2000) 1.16

Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am J Physiol (1982) 1.15

Gastric loads and cholecystokinin synergistically stimulate rat gastric vagal afferents. Am J Physiol (1993) 1.15

Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary. Clin Endocrinol (Oxf) (1984) 1.15

Co-localization of vasoactive intestinal peptide (VIP) and enkephalins in chromaffin cells of the adrenal gland of amphibia. Stimulation of corticosteroid production by VIP. Life Sci (1983) 1.14

Management of maladaptive behavior of a severely burned child. Child Welfare (1973) 1.14

Time course of effects of preloads high in fat or carbohydrate on food intake and hunger ratings in humans. Am J Physiol (1991) 1.14

Early and persistent abnormalities in rats with neonatally acquired Borna disease virus infection. Brain Res Bull (1994) 1.12

Somatostatin receptor-mediated signaling in smooth muscle. Activation of phospholipase C-beta3 by Gbetagamma and inhibition of adenylyl cyclase by Galphai1 and Galphao. J Biol Chem (1996) 1.12

The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones. Clin Endocrinol (Oxf) (1986) 1.12

Comparison of the distribution of dynorphin systems and enkephalin systems in brain. Science (1982) 1.11

Analogs of luteinizing hormone-releasing hormone with increased biological activity produced by D-amino acid substitutions in position 6. J Med Chem (1976) 1.10

Characterisation of an mRNA encoding a metallothionein-like protein that accumulates during ethylene-promoted abscission of Sambucus nigra L. leaflets. Planta (1995) 1.10

Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol Pharmacol (1993) 1.09

Detecting fMRI activation allowing for unknown latency of the hemodynamic response. Neuroimage (2005) 1.08

Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Mol Pharmacol (2000) 1.08

CCK elicits and modulates vagal afferent activity arising from gastric and duodenal sites. Ann N Y Acad Sci (1994) 1.07

Synthesis and biological actions of prosomatostatin. Proc Natl Acad Sci U S A (1980) 1.07

Highly active position eight analogues of somatostatin and separation of peptide diastereomers by partition chromatography. Biochemistry (1978) 1.07

Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes. Eur J Pharmacol (1998) 1.07

Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat. Peptides (1983) 1.07

Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches. Brain Res (1987) 1.06

Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest (1997) 1.06

An analog of enkephalin having prolonged opiate-like effects in vivo. Science (1977) 1.06

Decreased responsiveness to dietary fat in Otsuka Long-Evans Tokushima fatty rats lacking CCK-A receptors. Am J Physiol (1999) 1.05

Proceedings: Effect of somatostatin on motilin levels and gastric emptying. Gut (1975) 1.05

The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum (1984) 1.04

Leptin amplifies the feeding inhibition and neural activation arising from a gastric nutrient preload. Physiol Behav (2001) 1.03

Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. Endocrinology (1985) 1.03

Glucagon control of fasting glucose in man. Lancet (1974) 1.02

Stimulation of cyclic AMP accumulation and corticotropin release by synthetic ovine corticotropin-releasing factor in rat anterior pituitary cells: site of glucocorticoid action. Proc Natl Acad Sci U S A (1982) 1.02

Comparison of methionine-enkephalin and morphine in the stimulation of gastric acid secretion in the dog. Gastroenterology (1980) 1.02

The iron(3)-catalyzed oxidation of cysteine by molecular oxygen in the aqueous phase. An example of a two-thirds-order reaction. J Am Chem Soc (1966) 1.02

Developmental injury to the cerebellum following perinatal Borna disease virus infection. Brain Res Dev Brain Res (1995) 1.02

Gut vagal afferent lesions increase meal size but do not block gastric preload-induced feeding suppression. Am J Physiol (1999) 1.01

Corticotropin-releasing factor stimulates accumulation of adenosine 3', 5'-monophosphate in rat pituitary corticotrophs. Science (1982) 1.00

Differences between pig tissues in the expression of major transplantation antigens: possible relevance for organ allografts. J Exp Med (1976) 1.00

Gastrin secretion from human antral G cells in culture. Gastroenterology (1990) 1.00

Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt. J Clin Endocrinol Metab (2001) 1.00

Carrier-mediated transport of enkephalins and N-Tyr-MIF-1 across blood-brain barrier. Am J Physiol (1986) 0.99

Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. Endocrinology (1985) 0.99

Hindbrain GRP receptor blockade antagonizes feeding suppression by peripherally administered GRP. Am J Physiol (1996) 0.99

Fungal pathogens of Proteaceae. Persoonia (2011) 0.99

Inhibition of pancreatic secretion by enkephalin and morphine in dogs. Gastroenterology (1978) 0.99

Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol (1991) 0.98

Angiosarcomas of the uterus and ovary: clinicopathologic report. Cancer (1982) 0.98

Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Brain Res (1993) 0.97

Recent approaches to fertility control based on derivative of LH-RH. Vitam Horm (1980) 0.97

An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha. Endocrinology (1998) 0.97

Reversal of somatostatin inhibition of insulin and glucagon secretion. Diabetes (1976) 0.97

Meal-related stimuli differentially induce c-Fos activation in the nucleus of the solitary tract. Am J Physiol Regul Integr Comp Physiol (2001) 0.97

Borna disease virus-induced hippocampal dentate gyrus damage is associated with spatial learning and memory deficits. Brain Res Bull (1999) 0.97

The somatostatin receptor subtype on rat enterochromaffinlike cells. Gastroenterology (1994) 0.97